Go Pro

Wellington Management Group LLP Purchases 1,625,360 Shares of Envista Holdings Corporation $NVST

Envista logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wellington Management sharply increased its Envista stake by purchasing 1,625,360 shares during the second quarter, bringing its holdings to 1.69 million shares valued at approximately $44.4 million, or 1.05% of the company.
  • Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $29.71, compared with the stock’s reported price of $27.53.
  • Envista exceeded quarterly expectations, reporting adjusted EPS of $0.41 versus the $0.34 consensus and revenue of $730.5 million, up 7.1% year over year; management issued fiscal 2026 EPS guidance of $1.50–$1.55.
  • Five stocks we like better than Envista.

Wellington Management Group LLP increased its position in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) by 2,662.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,686,415 shares of the company's stock after acquiring an additional 1,625,360 shares during the quarter. Wellington Management Group LLP owned about 1.05% of Envista worth $44,437,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Envista in the second quarter worth about $25,000. Caitong International Asset Management Co. Ltd grew its holdings in shares of Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company's stock valued at $31,000 after buying an additional 1,504 shares during the last quarter. Allworth Financial LP raised its stake in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company's stock worth $39,000 after acquiring an additional 776 shares during the last quarter. UMB Bank n.a. lifted its position in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company's stock worth $44,000 after acquiring an additional 636 shares during the period. Finally, IFP Advisors Inc grew its stake in Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company's stock valued at $46,000 after purchasing an additional 1,071 shares during the last quarter.

Insider Activity

In other news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the transaction, the senior vice president owned 27,321 shares in the company, valued at $751,327.50. This trade represents a 22.65% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on NVST. Mizuho set a $29.00 price target on shares of Envista in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft set a $32.00 target price on shares of Envista in a research report on Thursday. Barclays reduced their price objective on Envista from $34.00 to $32.00 and set an "overweight" rating for the company in a research note on Thursday, June 11th. Morgan Stanley set a $23.00 target price on Envista in a report on Thursday, August 6th. Finally, BMO Capital Markets assumed coverage on Envista in a research report on Wednesday, July 8th. They issued a "market perform" rating and a $27.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $29.71.

View Our Latest Stock Report on NVST

Envista Price Performance

NYSE:NVST opened at $27.53 on Friday. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The stock's 50-day moving average price is $27.22 and its 200-day moving average price is $26.29. The stock has a market capitalization of $4.42 billion, a PE ratio of 47.47, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86.

Envista (NYSE:NVST - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. During the same quarter in the prior year, the business posted $0.26 earnings per share. Envista's revenue for the quarter was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

About Envista

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines